Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
TB-500 safety data in humans is limited to the wound healing trial, which reported no serious adverse events in the active treatment group 33
Inject subcutaneously below the medial malleolus, avoiding the posterior tibial artery
The benzyl alcohol content inhibits bacterial growth, allowing multiple withdrawals from a single vial while maintaining sterility unlike standard sterile water which is single-use only
Most protocols recommend cycling (8 to 12 weeks on, 4 to 8 weeks off) rather than continuous use
BPC-157 injections have been discussed in preclinical studies involving systemic effects, tissue biology, tendon biology models, and research involving damaged tissue
.jpg?width=602&height=602&name=Final%20(2).jpg)
